← Leaderboards
Johanna Catharina Vanderspek
Anjin Group, Inc.
$567,216
Attributed
$567,216
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $270.3K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$567,216 · 4
By mechanism
R43$567,216 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsTherapeutic AgentsIn VitroPharmaceutical PreparationsRecurrenceT-Cell LymphomaFusion ToxinInterleukin 2 ReceptorCellsMutantPublic Health Medicine (Field)RangeSalesCutaneousBlood VesselsExtravasationCytotoxicityAdverse EffectsDenileukin DiftitoxDiphtheria ToxinChimeric ProteinsBaseClassToxin
Grant awards (4)
Further Analysis of a VLS Modified IL-2 Receptor Targeted Toxin$147,459
R43 · FY2008 · AI · contact PI
Generation of a Modified DT_IL3 Fusion Toxin$122,830
R43 · FY2008 · CA · contact PI
Modified Diphtheria Toxin IL-7 Fusion Toxins$152,141
R43 · FY2006 · CA · contact PI
An IL-2 Receptor Targeted Toxin with Reduced VLS$144,786
R43 · FY2005 · AI